349 related articles for article (PubMed ID: 30285805)
1. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
[TBL] [Abstract][Full Text] [Related]
2. Interaction with SP1, but not binding to the E-box motifs, is responsible for BHLHE40/DEC1-induced transcriptional suppression of CLDN1 and cell invasion in MCF-7 cells.
Zheng Q; Wang C; Wang L; Zhang D; Liu N; Ming X; Zhou H; Guli Q; Liu Y
Mol Carcinog; 2018 Sep; 57(9):1116-1129. PubMed ID: 29704436
[TBL] [Abstract][Full Text] [Related]
3. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
4. Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance.
Zhang H; Fredericks T; Xiong G; Qi Y; Rychahou PG; Li JD; Pihlajaniemi T; Xu W; Xu R
Breast Cancer Res; 2018 Oct; 20(1):116. PubMed ID: 30285809
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties.
Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Rafii S; Rafii A
PLoS One; 2014; 9(11):e112424. PubMed ID: 25380486
[TBL] [Abstract][Full Text] [Related]
7. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
8. Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40.
Yin Y; Xin Y; Zhang F; An D; Fan H; Qin M; Xia J; Xi T; Xiong J
Neoplasia; 2023 May; 39():100891. PubMed ID: 36931039
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor.
Bolnick AD; Bolnick JM; Kohan-Ghadr HR; Kilburn BA; Pasalodos OJ; Singhal PK; Dai J; Diamond MP; Armant DR; Drewlo S
Hum Reprod; 2017 Jun; 32(6):1218-1229. PubMed ID: 28402449
[TBL] [Abstract][Full Text] [Related]
10. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.
Xiong G; Deng L; Zhu J; Rychahou PG; Xu R
BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4.
He L; Deng H; Liu S; Chen J; Li B; Wang C; Wang X; Jiang Y; Ma N; Liu M; Xie D
Cancer Commun (Lond); 2018 Aug; 38(1):53. PubMed ID: 30103827
[TBL] [Abstract][Full Text] [Related]
12. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
Zhou ZN; Sharma VP; Beaty BT; Roh-Johnson M; Peterson EA; Van Rooijen N; Kenny PA; Wiley HS; Condeelis JS; Segall JE
Oncogene; 2014 Jul; 33(29):3784-93. PubMed ID: 24013225
[TBL] [Abstract][Full Text] [Related]
13. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
Cancer Lett; 2018 Dec; 438():165-173. PubMed ID: 30227220
[TBL] [Abstract][Full Text] [Related]
14. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
[TBL] [Abstract][Full Text] [Related]
15. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
16. Genomic pathways modulated by Twist in breast cancer.
Vesuna F; Bergman Y; Raman V
BMC Cancer; 2017 Jan; 17(1):52. PubMed ID: 28086829
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of INHBA mediated by the transcription factor BHLHE40 promotes colon cancer cell proliferation and migration.
Wang J; Li B; Yang S; Ma C; Liu K; Chen X; Cui W
J Clin Lab Anal; 2022 Jul; 36(7):e24539. PubMed ID: 35689549
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signaling.
DeVaux RS; Ropri AS; Grimm SL; Hall PA; Herrera EO; Chittur SV; Smith WP; Coarfa C; Behbod F; Herschkowitz JI
J Cell Biochem; 2020 Jul; 121(7):3465-3478. PubMed ID: 31907974
[TBL] [Abstract][Full Text] [Related]
19. Bhlhe40 Represses PGC-1α Activity on Metabolic Gene Promoters in Myogenic Cells.
Chung SY; Kao CH; Villarroya F; Chang HY; Chang HC; Hsiao SP; Liou GG; Chen SL
Mol Cell Biol; 2015 Jul; 35(14):2518-29. PubMed ID: 25963661
[TBL] [Abstract][Full Text] [Related]
20. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
